Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Resistance”

479 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 479 results

Not applicableWithdrawnNCT00700362
What this trial is testing

Insulin Infusion and Infectious Diabetic Foot Ulcers (IIIFU)

Who this might be right for
Diabetes MellitusInsulin ResistanceHyperglycemia+1 more
Karolinska Institutet
Not applicableStudy completedNCT01099943
What this trial is testing

Reducing Inappropriate Antibiotic Prescribing by Primary Care Clinicians

Who this might be right for
Increased Drug ResistanceInfectious Diseases
University of Colorado, Denver 8
Large-scale testing (Phase 3)Not Yet RecruitingNCT06751485
What this trial is testing

JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerPrimary PeritonealFallopian Tube Cancers
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 430
Testing effectiveness (Phase 2)WithdrawnNCT06545617
What this trial is testing

A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer

Who this might be right for
Platinum-resistant Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Bio-Thera Solutions
Post-approval studies (Phase 4)Study completedNCT02633046
What this trial is testing

Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria

Who this might be right for
Idiopathic Focal Segmental Glomerulosclerosis
Mallinckrodt ARD LLC 63
Testing effectiveness (Phase 2)Study completedNCT01196559
What this trial is testing

Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
The Catholic University of Korea 44
Testing effectiveness (Phase 2)Study completedNCT01604096
What this trial is testing

Controlled Trial to Evaluate a Local Information Campaign on Antibiotic Prescribing in Italy

Who this might be right for
Upper Respiratory Tract Infections
Regional Health and Social Care Agency, Italy
Testing effectiveness (Phase 2)UnknownNCT04376073
What this trial is testing

Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian Cancer
Jihong Liu 40
Large-scale testing (Phase 3)Study completedNCT04296890
What this trial is testing

Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression

Who this might be right for
Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer
ImmunoGen, Inc. 106
Not applicableUnknownNCT01742702
What this trial is testing

HaemoDYNAMICs in Primary and Secondary Hypertension

Who this might be right for
Primary HypertensionSecondary HypertensionAortic Stenosis+1 more
Tampere University 2,000
Not applicableStudy completedNCT04568954
What this trial is testing

TB-CAPT CORE Truenat Trial

Who this might be right for
TuberculosisDiagnoses Disease
Foundation for Innovative New Diagnostics, Switzerland 3,987
Not applicableLooking for participantsNCT06662461
What this trial is testing

Ultrasound Guided Block of Stellate Ganglion Versus Greater Occipital Nerve in Resistant Migraine and Correlation to Calcitonin Gene Related Peptide

Who this might be right for
Migraine
Ain Shams University 40
Testing effectiveness (Phase 2)Ended earlyNCT05538624
What this trial is testing

Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary

Who this might be right for
Neoplasm, OvarianFallopian Tube CancerPrimary Peritoneal Cavity Cancer+5 more
Avenge Bio, Inc 14
Not applicableStudy completedNCT03917212
What this trial is testing

Energy Metabolism in Branched-chain Organic Acidemias

Who this might be right for
Energy MetabolismMetabolic SyndromeInsulin Resistance
German Diabetes Center 57
Large-scale testing (Phase 3)Study completedNCT03559257
What this trial is testing

Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine

Who this might be right for
Migraine
Eli Lilly and Company 463
Large-scale testing (Phase 3)Active Not RecruitingNCT06619236
What this trial is testing

Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian Cancer
Genmab 530
Testing effectiveness (Phase 2)Looking for participantsNCT07024784
What this trial is testing

Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Who this might be right for
Gynecologic CancersPlatinum-Sensitive Ovarian CancerFallopian Tube Cancer+1 more
AbbVie 377
Not applicableStudy completedNCT04990596
What this trial is testing

Mechanisms fo Clopidogrel Resistance in Older Adults (CEPAGE)

Who this might be right for
Drug Resistance
Rennes University Hospital 37
Very early researchActive Not RecruitingNCT05053750
What this trial is testing

TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Epithelial OvarianFallopian TubePrimary Peritoneal Cancer
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Ended earlyNCT05261490
What this trial is testing

Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer

Who this might be right for
Ovarian CancerOvarian NeoplasmsOvarian Carcinoma+3 more
Pfizer 10
Load More Results